GI
AKTS icon

GAMMA Investing’s Aktis Oncology AKTS Stock Holding History

GAMMA Investing’s Portfolio AKTS Stock Details AKTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.1K Buy
108
+88
+440% +$2.14K ﹤0.01% 3942
2026
Q2 		$645 Buy
+20
New +$411 ﹤0.01% 3950

Other funds holding AKTS

MCP
Mirador Capital Partners Pleasanton, California $859M AUM 41.74% 1-Year Est. Return
GWM
GK Wealth Management Reno, Nevada $178M AUM 41.48% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
EP
Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return

GAMMA Investing's AKTS Position: Q3 2026 in Review

GAMMA Investing increased its Aktis Oncology (AKTS) stake by 440% in Q3 2026, buying an estimated $2.14K and bringing the position to 108 shares worth $2.1K. The position accounts for ﹤0.01% of the portfolio, ranked #3942.

GAMMA Investing first reported a position in AKTS in Q2 2026 and has held it in 2 quarters since. 6 funds tracked by Wall St. Rank hold AKTS as of Q3 2026.

  • GAMMA Investing held 108 shares of Aktis Oncology worth $2.1K as of Q3 2026.
  • GAMMA Investing bought 88 Aktis Oncology shares in Q3 2026, an estimated $2.14K.
  • Aktis Oncology made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #3942 holding.
  • GAMMA Investing first reported a position in Aktis Oncology in Q2 2026 and has held it in 2 quarters since.
  • 6 funds tracked by Wall St. Rank held Aktis Oncology as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.